PTC Therapeutics, Inc. (PTCT)
USD 41.88
(-3.15%)
USD 41.88
(-3.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -330.34 Million USD | 69.72% |
| 2022 | -367.78 Million USD | 1.45% |
| 2021 | -374.44 Million USD | -65.95% |
| 2020 | -297 Million USD | -95.07% |
| 2019 | -191.37 Million USD | -115.76% |
| 2018 | -89.46 Million USD | -10.66% |
| 2017 | -46.61 Million USD | 62.96% |
| 2016 | -128.76 Million USD | 20.98% |
| 2015 | -164.25 Million USD | -68.12% |
| 2014 | -97.17 Million USD | -131.89% |
| 2013 | -43 Million USD | -77.86% |
| 2012 | -24.1 Million USD | -172.05% |
| 2011 | 33.45 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -26.33 Million USD | -405.43% |
| 2024 Q1 | 9.84 Million USD | 135.96% |
| 2023 FY | - USD | 69.72% |
| 2023 Q4 | 83.82 Million USD | 170.94% |
| 2023 Q1 | -65.84 Million USD | 26.63% |
| 2023 Q3 | -118.16 Million USD | -73.37% |
| 2023 Q2 | -68.15 Million USD | -3.52% |
| 2022 Q2 | -112.73 Million USD | -34.59% |
| 2022 Q3 | -77.15 Million USD | 31.57% |
| 2022 Q4 | -89.74 Million USD | -16.33% |
| 2022 FY | - USD | 1.45% |
| 2022 Q1 | -83.76 Million USD | 25.12% |
| 2021 FY | - USD | -65.95% |
| 2021 Q4 | -111.86 Million USD | -32.69% |
| 2021 Q3 | -84.3 Million USD | -5.87% |
| 2021 Q2 | -79.63 Million USD | 16.47% |
| 2021 Q1 | -95.34 Million USD | -409.16% |
| 2020 Q2 | -106.24 Million USD | -9.89% |
| 2020 FY | - USD | -95.07% |
| 2020 Q1 | -96.68 Million USD | -141.65% |
| 2020 Q3 | -6.15 Million USD | 94.21% |
| 2020 Q4 | -18.72 Million USD | -204.39% |
| 2019 Q2 | -20.45 Million USD | 1.38% |
| 2019 Q3 | -33.33 Million USD | -62.94% |
| 2019 FY | - USD | -115.76% |
| 2019 Q1 | -20.74 Million USD | -5138.13% |
| 2019 Q4 | -40.01 Million USD | -20.04% |
| 2018 Q3 | -41.15 Million USD | -6461.21% |
| 2018 Q4 | -396 Thousand USD | 99.04% |
| 2018 FY | - USD | -10.66% |
| 2018 Q2 | 647 Thousand USD | 106.03% |
| 2018 Q1 | -10.72 Million USD | -198.54% |
| 2017 Q4 | 10.88 Million USD | 152.82% |
| 2017 FY | - USD | 62.96% |
| 2017 Q1 | -25.74 Million USD | -3.0% |
| 2017 Q2 | -12.49 Million USD | 51.45% |
| 2017 Q3 | -20.59 Million USD | -64.82% |
| 2016 Q1 | -37.59 Million USD | 22.01% |
| 2016 FY | - USD | 20.98% |
| 2016 Q3 | -31.25 Million USD | 12.57% |
| 2016 Q4 | -24.99 Million USD | 20.03% |
| 2016 Q2 | -35.74 Million USD | 4.92% |
| 2015 FY | - USD | -68.12% |
| 2015 Q4 | -48.2 Million USD | -16.23% |
| 2015 Q3 | -41.47 Million USD | -7.37% |
| 2015 Q2 | -38.62 Million USD | -1.46% |
| 2015 Q1 | -38.07 Million USD | -18.12% |
| 2014 Q1 | -13.62 Million USD | 22.18% |
| 2014 FY | - USD | -131.89% |
| 2014 Q3 | -27.05 Million USD | -9.07% |
| 2014 Q4 | -32.23 Million USD | -19.11% |
| 2014 Q2 | -24.8 Million USD | -82.08% |
| 2013 Q3 | -3.55 Million USD | 75.42% |
| 2013 Q4 | -17.5 Million USD | -392.17% |
| 2013 FY | - USD | -77.86% |
| 2013 Q1 | -7.89 Million USD | -46.82% |
| 2013 Q2 | -14.47 Million USD | -83.25% |
| 2012 Q1 | -5.47 Million USD | 0.0% |
| 2012 FY | - USD | -172.05% |
| 2012 Q3 | -6.38 Million USD | -26.46% |
| 2012 Q4 | -5.37 Million USD | 15.79% |
| 2012 Q2 | -5.05 Million USD | 7.7% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -71.911% |
| Alkermes plc | 495.04 Million USD | 166.729% |
| Agenus Inc. | -145.92 Million USD | -126.378% |
| Aptorum Group Limited | -9.59 Million USD | -3341.401% |
| Ardelyx, Inc. | -55.35 Million USD | -496.777% |
| Dyadic International, Inc. | -8.22 Million USD | -3913.979% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -113418.9% |
| Lantern Pharma Inc. | -15.78 Million USD | -1992.522% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1558.967% |
| Novavax, Inc. | -487.39 Million USD | 32.223% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -365.11% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -320.853% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1737.933% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3214.005% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -475.747% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 13.061% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1270.029% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 62546.125% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -110.147% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -341.543% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1538.673% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1291.784% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1332.648% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -170.542% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -27.919% |
| AlloVir, Inc. | -190.14 Million USD | -73.73% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -88.044% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1029.059% |
| Bicycle Therapeutics plc | -183.4 Million USD | -80.12% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -99.697% |
| ChromaDex Corporation | -3.89 Million USD | -8383.308% |
| Chimerix, Inc. | -92.97 Million USD | -255.304% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -643.395% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -193.547% |
| CRISPR Therapeutics AG | -202.7 Million USD | -62.969% |
| Precision BioSciences, Inc. | -32.04 Million USD | -930.959% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -91.803% |
| Fortress Biotech, Inc. | -133.64 Million USD | -147.181% |
| Fortress Biotech, Inc. | -133.64 Million USD | -147.181% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -327.11% |
| ImmuCell Corporation | -2.5 Million USD | -13092.086% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -153.287% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1947.269% |
| Incyte Corporation | 919.42 Million USD | 135.929% |
| Innoviva, Inc. | 248.96 Million USD | 232.688% |
| IO Biotech, Inc. | -91.22 Million USD | -262.104% |
| Jaguar Health, Inc. | -33.13 Million USD | -897.072% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -117.076% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 424.732% |
| ContextLogic Inc. | -324 Million USD | -1.957% |
| MiMedx Group, Inc. | 40.51 Million USD | 915.312% |
| MEI Pharma, Inc. | 26.38 Million USD | 1352.237% |
| NextCure, Inc. | -59.03 Million USD | -459.528% |
| Onconetix, Inc. | -36.7 Million USD | -799.944% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 14880.313% |
| Opthea Limited | -200.01 Million USD | -65.155% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -11905.466% |
| Vaxcyte, Inc. | -464.88 Million USD | 28.942% |
| PDS Biotechnology Corporation | -40.08 Million USD | -724.099% |
| Precigen, Inc. | -89.22 Million USD | -270.228% |
| Pharming Group N.V. | 9.87 Million USD | 3444.538% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -107.697% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1351.278% |
| PureTech Health plc | -11.62 Million USD | -2741.146% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1845.351% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -41.475% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1270.029% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -277.847% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1040.559% |
| Acelyrin, Inc. | -381.52 Million USD | 13.416% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2563678.193% |
| Summit Therapeutics Inc. | 1 Million USD | 33100.999% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -889.457% |
| Senti Biosciences, Inc. | -61.33 Million USD | -438.574% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -194.148% |
| Elevation Oncology, Inc. | -41.46 Million USD | -696.633% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -968.923% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -5300.76% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -102809.657% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -917.903% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -3834.493% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -461.898% |
| Seer, Inc. | -97.88 Million USD | -237.478% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -431.119% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -405.377% |
| ESSA Pharma Inc. | -26.45 Million USD | -1148.672% |
| GlycoMimetics, Inc. | -39.12 Million USD | -744.384% |
| GT Biopharma, Inc. | 5.97 Million USD | 5625.004% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -59.822% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -4709.843% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 480.523% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -482.056% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -544.956% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3241.187% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 38.818% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -4698.664% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -604.921% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -39.607% |
| Aptose Biosciences Inc. | -52.26 Million USD | -532.012% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -206.599% |
| Soligenix, Inc. | -7.85 Million USD | -4106.626% |
| Century Therapeutics, Inc. | -121.2 Million USD | -172.54% |
| Kura Oncology, Inc. | -164.95 Million USD | -100.261% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -312.42% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3175.233% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -34391.652% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -7566.28% |
| Autolus Therapeutics plc | -156.77 Million USD | -110.716% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -290.21% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -378.747% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1557.169% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -74.531% |
| GRI Bio, Inc. | -10.89 Million USD | -2931.198% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -7215.342% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -169.652% |
| IGM Biosciences, Inc. | -253.35 Million USD | -30.385% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -218.271% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -766.279% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2054.732% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1998.297% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -481.124% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -208.432% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -24.189% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -70.332% |
| Verastem, Inc. | -83.16 Million USD | -297.206% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -553.207% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -108.775% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -189.546% |
| Histogen Inc. | -10.5 Million USD | -3045.197% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2213.353% |
| Surrozen, Inc. | -41.13 Million USD | -703.141% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2131.123% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 10300692.454% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -462.633% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -544.013% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1433.683% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -3861.859% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -98.921% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -570.626% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1266.962% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2094.216% |
| Apollomics, Inc. | -171.74 Million USD | -92.341% |
| Amarin Corporation plc | -50.9 Million USD | -548.979% |
| Mesoblast Limited | -61.33 Million USD | -438.618% |
| Turnstone Biologics Corp. | -56.23 Million USD | -487.438% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -130.683% |
| Synaptogenix, Inc. | -8.3 Million USD | -3876.404% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2053.595% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -423.958% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6794.341% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 77095.331% |
| Exelixis, Inc. | 196.6 Million USD | 268.025% |
| Better Therapeutics, Inc. | -38.26 Million USD | -763.363% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -133.606% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 33.293% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2700.523% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 133724.037% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1019.569% |
| Gritstone bio, Inc. | -126.86 Million USD | -160.391% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -408.333% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -8158.611% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2777.275% |
| Insmed Incorporated | -654.73 Million USD | 49.546% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -14583.612% |
| MediWound Ltd. | -4.89 Million USD | -6651.277% |
| OmniAb, Inc. | -49.73 Million USD | -564.254% |
| Alector, Inc. | -142.89 Million USD | -131.182% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -286.661% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -533.466% |
| Zai Lab Limited | -366.57 Million USD | 9.884% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -13.661% |
| Aura Biosciences, Inc. | -83.69 Million USD | -294.69% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -46.655% |
| Immunic, Inc. | -99.11 Million USD | -233.3% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -150.885% |
| Veracyte, Inc. | -49.4 Million USD | -568.583% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -4576.433% |
| FibroGen, Inc. | -261.4 Million USD | -26.371% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2865.084% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4618.248% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1664.932% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 122.791% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1199.426% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 928.127% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1365.67% |
| Galecto, Inc. | -37.51 Million USD | -780.461% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -763.295% |
| Fortrea Holdings Inc. | 167.3 Million USD | 297.454% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -146.008% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1066.826% |
| XBiotech Inc. | -35.76 Million USD | -823.615% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -408.333% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -406.268% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -216.251% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1186.772% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -708.329% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 36.037% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -489.672% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -589256.122% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -183.956% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1390.062% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -40.532% |
| NexImmune, Inc. | -28.16 Million USD | -1072.77% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -5878.412% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -2701.326% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 107.098% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1200.961% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2720.249% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -162.495% |
| Ainos, Inc. | -8.77 Million USD | -3665.375% |
| Pluri Inc. | -20.22 Million USD | -1533.325% |
| Prothena Corporation plc | -190.1 Million USD | -73.764% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -157.68% |
| Celularity Inc. | -183.94 Million USD | -79.585% |
| Rallybio Corporation | -72.37 Million USD | -356.441% |
| Cue Biopharma, Inc. | -46.05 Million USD | -617.32% |
| MeiraGTx Holdings plc | -57.05 Million USD | -479.016% |
| Omeros Corporation | -163.61 Million USD | -101.907% |
| Humacyte, Inc. | -96.45 Million USD | -242.47% |
| Immunocore Holdings plc | -59.64 Million USD | -453.806% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1605.245% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1255.797% |
| Blueprint Medicines Corporation | -474.61 Million USD | 30.398% |
| CalciMedica, Inc. | -34.18 Million USD | -866.217% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -351.075% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -163.225% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -96.105% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -30.885% |
| Pulmatrix, Inc. | -12.64 Million USD | -2512.209% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -902.063% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -273.405% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 34.756% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -226.375% |
| Cytokinetics, Incorporated | -456.68 Million USD | 27.666% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -889.842% |
| Nutriband Inc. | -5.12 Million USD | -6349.715% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -663.404% |
| Vor Biopharma Inc. | -114.37 Million USD | -188.832% |
| Roivant Sciences Ltd. | -996.51 Million USD | 66.85% |
| Evogene Ltd. | -23.2 Million USD | -1323.634% |
| ProKidney Corp. | -147.66 Million USD | -123.703% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -411.877% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -215598.437% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 41.581% |
| CorMedix Inc. | -48.88 Million USD | -575.721% |
| BioLineRx Ltd. | -57.06 Million USD | -478.924% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -195.585% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -163434.653% |
| Atai Life Sciences N.V. | -36.31 Million USD | -809.752% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -315.433% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -306.257% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -19.904% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -974.626% |
| MediciNova, Inc. | -9.87 Million USD | -3243.532% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -162.297% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -21488.014% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1138.677% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -46.824% |
| Biomea Fusion, Inc. | -124.62 Million USD | -165.078% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1167.808% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -73.554% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -43.662% |
| Absci Corporation | -95.45 Million USD | -246.062% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1000.216% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -208.389% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -41.488% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1345.373% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -58.943% |
| Allakos Inc. | -189.91 Million USD | -73.941% |
| Imunon, Inc. | -19.87 Million USD | -1561.814% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -204.483% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 404.956% |
| BioAtla, Inc. | -122.24 Million USD | -170.237% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2700.523% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1995.933% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -10.006% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -697.018% |
| XOMA Corporation | -39.36 Million USD | -739.236% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -232.823% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -180.782% |
| aTyr Pharma, Inc. | -52.17 Million USD | -533.102% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -294.13% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -122.255% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -40.831% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2319.541% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -4007.531% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1866.075% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 175155.377% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 173.093% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5070.753% |
| UroGen Pharma Ltd. | -63.83 Million USD | -417.523% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -386.402% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -4448.251% |
| Orgenesis Inc. | -60.71 Million USD | -444.056% |
| Entera Bio Ltd. | -8.8 Million USD | -3652.158% |
| GH Research PLC | -41.15 Million USD | -702.712% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1194.486% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -301.712% |
| Xencor, Inc. | -125.87 Million USD | -162.437% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -23056.648% |
| Replimune Group, Inc. | -230.19 Million USD | -43.503% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1538.785% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2919.009% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5070.753% |
| Portage Biotech Inc. | -18.19 Million USD | -1715.155% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -21488.014% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -215.861% |
| OncoCyte Corporation | -23.12 Million USD | -1328.621% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2823.269% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2783.343% |
| Purple Biotech Ltd. | -22.22 Million USD | -1386.344% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -5053.51% |
| scPharmaceuticals Inc. | -46.06 Million USD | -617.179% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1754.834% |
| HilleVax, Inc. | -132.46 Million USD | -149.377% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3006.743% |
| Tharimmune, Inc. | -9.3 Million USD | -3451.054% |
| Genprex, Inc. | -31.06 Million USD | -963.535% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -76.157% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -953.582% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -43138.22% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 219007.385% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2097846.954% |
| Savara Inc. | -59.13 Million USD | -458.639% |
| Curis, Inc. | -45.13 Million USD | -631.828% |
| Daré Bioscience, Inc. | -30.7 Million USD | -975.973% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2074.556% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -4510.468% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1135.655% |
| BeiGene, Ltd. | -1.12 Billion USD | 70.626% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1926.477% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 23.281% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -265.663% |
| Erasca, Inc. | -121.31 Million USD | -172.311% |
| bluebird bio, Inc. | -167.16 Million USD | -97.618% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -7242.919% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 206.464% |
| DBV Technologies S.A. | -85.98 Million USD | -284.197% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -7242.919% |
| Moderna, Inc. | -3.28 Billion USD | 89.938% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -675.282% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -5748.796% |
| Molecular Templates, Inc. | 1.43 Million USD | 23200.699% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -451.928% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -1.255% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -140.968% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -597.42% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -137.597% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -60.468% |
| MacroGenics, Inc. | 2.01 Million USD | 16477.789% |
| RenovoRx, Inc. | -11.39 Million USD | -2800.263% |
| Adicet Bio, Inc. | -136.53 Million USD | -141.945% |
| Prime Medicine, Inc. | -193.75 Million USD | -70.49% |
| Aditxt, Inc. | -25.45 Million USD | -1197.59% |
| Adagene Inc. | -14.95 Million USD | -2109.516% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4418.954% |
| Quantum-Si incorporated | -91.8 Million USD | -259.832% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 146.369% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 361.231% |
| SciSparc Ltd. | -5.28 Million USD | -6154.07% |
| Vericel Corporation | 2.86 Million USD | 11634.218% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -346866.641% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1422.906% |
| Generation Bio Co. | -133.3 Million USD | -147.817% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -297.856% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -284.014% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -45.247% |
| Invivyd, Inc. | -196.61 Million USD | -68.014% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 11.71% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3461.695% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1316.543% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3111.862% |
| 2seventy bio, Inc. | -206.41 Million USD | -60.034% |
| ADMA Biologics, Inc. | 5.12 Million USD | 6551.953% |
| Clene Inc. | -43.24 Million USD | -663.951% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1335.701% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -581.437% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1138.677% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -10.273% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -799.39% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1501.349% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 6827.553% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -916.994% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -108.543% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 51.726% |
| Evaxion Biotech A/S | -21.4 Million USD | -1443.428% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -397.388% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -51.763% |
| Trevena, Inc. | -35.28 Million USD | -836.126% |
| Surrozen, Inc. | -41.13 Million USD | -703.141% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -315.042% |
| Cingulate Inc. | -22.95 Million USD | -1339.263% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -4327.557% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -786.034% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -3915.622% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -223.02% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -387.033% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -465.922% |
| Clearmind Medicine Inc. | -8.71 Million USD | -3692.364% |
| Kronos Bio, Inc. | -121.83 Million USD | -171.148% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -344.352% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -13430.683% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -227.63% |
| Statera Biopharma, Inc. | 38.93 Million USD | 948.441% |
| ImmunityBio, Inc. | -436.18 Million USD | 24.266% |
| Korro Bio, Inc. | -80.9 Million USD | -308.311% |
| Kineta, Inc. | -15.71 Million USD | -2002.202% |
| BioVie Inc. | -31.95 Million USD | -933.921% |
| Codexis, Inc. | -49.28 Million USD | -570.292% |
| Celularity Inc. | -183.94 Million USD | -79.585% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -49.131% |
| Celcuity Inc. | -58.3 Million USD | -466.524% |
| Virax Biolabs Group Limited | -6.6 Million USD | -4898.227% |
| Cibus, Inc. | -314.58 Million USD | -5.008% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -879.278% |
| IN8bio, Inc. | -28.5 Million USD | -1058.925% |
| Kodiak Sciences Inc. | -259.02 Million USD | -27.533% |
| Annexon, Inc. | -141.57 Million USD | -133.332% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -193.377% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -414.58% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1081.685% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -43.62% |
| Eyenovia, Inc. | -24.1 Million USD | -1270.362% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 837.63% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -101856.79% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -347.591% |
| Arcellx, Inc. | -64.14 Million USD | -414.989% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -633.861% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -167.534% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -969.685% |
| Moolec Science SA | -52.07 Million USD | -534.348% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -540.119% |
| Geron Corporation | -174.78 Million USD | -89.001% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -717.329% |
| Royalty Pharma plc | 1.88 Billion USD | 117.504% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -176.22% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3442.804% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1492.71% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -98.904% |
| Humacyte, Inc. | -96.45 Million USD | -242.47% |
| Structure Therapeutics Inc. | -102.45 Million USD | -222.412% |
| 89bio, Inc. | -134.46 Million USD | -145.674% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -318.815% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 8252.517% |
| Genelux Corporation | -24.16 Million USD | -1267.018% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -877.337% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -102.087% |
| Notable Labs, Ltd. | -14.4 Million USD | -2194.028% |
| Liquidia Corporation | -70.05 Million USD | -371.571% |
| Mustang Bio, Inc. | -48.06 Million USD | -587.306% |
| Immunovant, Inc. | -269.97 Million USD | -22.358% |
| Quantum-Si incorporated | -91.8 Million USD | -259.832% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -365.359% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1610.897% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -223.825% |
| Acasti Pharma Inc. | -11.3 Million USD | -2823.104% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1384.458% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2054.732% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -56.921% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -7635.678% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1980.227% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1047.971% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -792.087% |
| PepGen Inc. | -83.58 Million USD | -295.229% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1019.645% |
| United Therapeutics Corporation | 1.38 Billion USD | 123.82% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1342.722% |
| Solid Biosciences Inc. | -93.43 Million USD | -253.554% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -6822.847% |
| Immuneering Corporation | -58.06 Million USD | -468.955% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 10300692.454% |
| Silo Pharma, Inc. | -3.62 Million USD | -9009.777% |
| Belite Bio, Inc | -31.52 Million USD | -947.734% |
| XOMA Corporation | -39.36 Million USD | -739.236% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -389.777% |
| Bionomics Limited | -9.83 Million USD | -3258.139% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -293.332% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -854.574% |
| uniQure N.V. | -253.1 Million USD | -30.518% |
| Cassava Sciences, Inc. | -95.68 Million USD | -245.23% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4418.954% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -155.081% |
| Forte Biosciences, Inc. | -32.47 Million USD | -917.151% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -4003.361% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1070.63% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -101856.79% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2865.084% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1977.479% |
| Altimmune, Inc. | -87.93 Million USD | -275.664% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -258.757% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -854.574% |
| Compugen Ltd. | -12.51 Million USD | -2539.342% |
| Peak Bio, Inc. | -1356.23 USD | -24357125.544% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -579.74% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1368.831% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -36.333% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1057.342% |
| Zura Bio Limited | -60.56 Million USD | -445.449% |
| PolyPid Ltd. | -20.26 Million USD | -1530.262% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2015.801% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1057.342% |
| Instil Bio, Inc. | -146.12 Million USD | -126.071% |
| argenx SE | -216.02 Million USD | -52.919% |
| Immunome, Inc. | -28.27 Million USD | -1068.477% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -581.493% |
| Verona Pharma plc | -52.46 Million USD | -529.608% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -248.563% |
| Shattuck Labs, Inc. | -87.61 Million USD | -277.036% |
| CervoMed Inc. | -2.17 Million USD | -15109.906% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -170.23% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2502.537% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -585.723% |
| Moolec Science SA | -52.07 Million USD | -534.348% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1827.306% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -153.346% |
| AnaptysBio, Inc. | -143.16 Million USD | -130.742% |
| Design Therapeutics, Inc. | -66.32 Million USD | -398.063% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -307.893% |
| NeurAxis, Inc. | -6.66 Million USD | -4856.715% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -775.073% |
| Lumos Pharma, Inc. | -36.57 Million USD | -803.309% |
| Achilles Therapeutics plc | -70.44 Million USD | -368.953% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -248.563% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1392.453% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 5766.941% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -13430.683% |
| Nutriband Inc. | -5.12 Million USD | -6349.715% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -200.999% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -495.937% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -553.492% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -406.059% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -510.498% |
| Palisade Bio, Inc. | -12.28 Million USD | -2589.846% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -628.006% |
| Beam Therapeutics Inc. | -156.47 Million USD | -111.116% |
| Neurogene Inc. | -52.28 Million USD | -531.794% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -142.025% |
| AEON Biopharma, Inc. | -48.36 Million USD | -583.071% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -255.136% |
| Sesen Bio, Inc. | -50.84 Million USD | -549.764% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -303.188% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2574.813% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 22.715% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -214.02% |
| Athira Pharma, Inc. | -116.7 Million USD | -183.06% |
| Vaccinex, Inc. | -19.74 Million USD | -1572.777% |
| HCW Biologics Inc. | -23.57 Million USD | -1301.167% |
| XOMA Corporation | -39.36 Million USD | -739.236% |
| Nektar Therapeutics | -243.1 Million USD | -35.883% |
| Arvinas, Inc. | -394.8 Million USD | 16.327% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 175155.377% |
| Merus N.V. | -149.2 Million USD | -121.397% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -253.343% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -956.75% |
| Rezolute, Inc. | -68.42 Million USD | -382.791% |
| Clene Inc. | -43.24 Million USD | -663.951% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2041.979% |
| BeyondSpring Inc. | -21.54 Million USD | -1433.612% |
| Synlogic, Inc. | -55.16 Million USD | -498.865% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2633.924% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3004.116% |
| Peak Bio, Inc. | -1356.23 USD | -24357125.544% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -917.527% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1945.063% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -178.949% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 3.224% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -7071.277% |
| MannKind Corporation | 15.12 Million USD | 2283.489% |
| Ikena Oncology, Inc. | -74.39 Million USD | -344.023% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2523.203% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1725.129% |
| Gossamer Bio, Inc. | -172.15 Million USD | -91.889% |
| CohBar, Inc. | -12.06 Million USD | -2637.83% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1194.994% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1000.216% |
| Legend Biotech Corporation | -477.87 Million USD | 30.873% |
| Mural Oncology plc | -192.72 Million USD | -71.409% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -189.635% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1946.048% |
| Disc Medicine, Inc. | -91.02 Million USD | -262.911% |
| Champions Oncology, Inc. | -5.05 Million USD | -6436.209% |
| REGENXBIO Inc. | -239.46 Million USD | -37.95% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2982.051% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -492.474% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -752.089% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -192.839% |
| Vaxart, Inc. | -74.72 Million USD | -342.086% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -838.245% |
| Cellectis S.A. | -98.09 Million USD | -236.755% |
| Longeveron Inc. | -20.06 Million USD | -1546.76% |
| Repare Therapeutics Inc. | -114.27 Million USD | -189.08% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 24.785% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -341.56% |
| Revolution Medicines, Inc. | -430.58 Million USD | 23.281% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -5152.663% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -972.916% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -342.874% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 6837.508% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2912.677% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 107.173% |
| Denali Therapeutics Inc. | -179.97 Million USD | -83.55% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -346866.641% |
| Veru Inc. | -89.97 Million USD | -267.144% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1129.035% |
| Cingulate Inc. | -22.95 Million USD | -1339.263% |
| Passage Bio, Inc. | -98.34 Million USD | -235.913% |
| Context Therapeutics Inc. | -25.06 Million USD | -1218.166% |
| Exicure, Inc. | -15.53 Million USD | -2025.877% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -60.309% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -793.39% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -5440.204% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -96.089% |
| Nuvalent, Inc. | -149.49 Million USD | -120.975% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -3962.016% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -284.59% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -994.638% |
| OmniAb, Inc. | -49.73 Million USD | -564.254% |
| Anew Medical, Inc. | -1.3 Million USD | -25294.361% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2571.789% |
| Lipocine Inc. | -16.32 Million USD | -1923.812% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -395.485% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -344.585% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -766.279% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -746.722% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1389.158% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 39.395% |
| Ocugen, Inc. | -64.82 Million USD | -409.572% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -256.854% |
| Q32 Bio Inc. | -86.5 Million USD | -281.887% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1851.557% |
| Alumis Inc. Common Stock | -156.89 Million USD | -110.555% |
| Equillium, Inc. | -12.13 Million USD | -2621.536% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -464.954% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4079.747% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1651.447% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -607.487% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -210.63% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1746.858% |
| Dominari Holdings Inc. | -22.44 Million USD | -1372.103% |
| Edesa Biotech, Inc. | -8.19 Million USD | -3933.386% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1199.937% |
| Bio-Techne Corporation | 326.66 Million USD | 201.126% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 14.167% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 252.66% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -151.96% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -782.531% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -118.622% |
| Nkarta, Inc. | -120.48 Million USD | -174.184% |
| BioCardia, Inc. | -11.56 Million USD | -2757.612% |
| Iterum Therapeutics plc | -34.58 Million USD | -855.292% |